Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ferrandiz

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
The British Journal of Dermatology|May 26, 2017
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III studyK Reich, A Pinter, J P Lacour, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2015
Patient-relevant needs and treatment goals in nail psoriasisC Blome, A Costanzo, E Dauden, et al.
The British Journal of Dermatology|October 15, 2013
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomesM Augustin, C Blome, A Costanzo, et al.
The British Journal of Dermatology|September 12, 2015
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)C Paul, J Cather, M Gooderham, et al.
Genome|May 10, 2008
The relationship between genetic and cytogenetic maps of pea. II. Physical maps of linkage mapping populationsK J Hall, J S Parker, T H Ellis, et al.
Actas Dermo-Sifiliograficas|June 10, 2020
[Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model]A Tejera-Vaquerizo, J Cañueto, A Toll, et al.
Actas Dermo-Sifiliograficas|July 30, 2013
Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and VenereologyG Carretero, M Ribera, I Belinchón, et al.
The British Journal of Dermatology|April 16, 2003
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategiesC Ellis, T Luger, D Abeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2012
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registryA I Sánchez-Moya, I García-Doval, G Carretero, et al.
Actas Dermo-Sifiliograficas|July 16, 2017
Guidelines on the Use of Methotrexate in PsoriasisG Carretero, L Puig, L Dehesa, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
The British Journal of Dermatology|May 26, 2017
Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III studyK Reich, A Pinter, J P Lacour, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2015
Patient-relevant needs and treatment goals in nail psoriasisC Blome, A Costanzo, E Dauden, et al.
The British Journal of Dermatology|October 15, 2013
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomesM Augustin, C Blome, A Costanzo, et al.
The British Journal of Dermatology|September 12, 2015
Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)C Paul, J Cather, M Gooderham, et al.
Genome|May 10, 2008
The relationship between genetic and cytogenetic maps of pea. II. Physical maps of linkage mapping populationsK J Hall, J S Parker, T H Ellis, et al.
Actas Dermo-Sifiliograficas|June 10, 2020
[Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model]A Tejera-Vaquerizo, J Cañueto, A Toll, et al.
Actas Dermo-Sifiliograficas|July 30, 2013
Guidelines for the use of acitretin in psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and VenereologyG Carretero, M Ribera, I Belinchón, et al.
The British Journal of Dermatology|April 16, 2003
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategiesC Ellis, T Luger, D Abeck, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 9, 2012
Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate-severe psoriasis in Spain. BIOBADADERM registryA I Sánchez-Moya, I García-Doval, G Carretero, et al.
Actas Dermo-Sifiliograficas|July 16, 2017
Guidelines on the Use of Methotrexate in PsoriasisG Carretero, L Puig, L Dehesa, et al.
Pageof 5